Silvia Lee

Dr. Silvia Lee

Harry Perkins Institute of Medical Research
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
BBBenjamin Bartlett
Benjamin Bartlett
HLHerbert P. Ludewick
Herbert P. Ludewick
AMAshish Misra
Ashish Misra
SLSilvia Lee
Silvia Lee
GDGirish Dwivedi
Girish Dwivedi
Atherosclerosis is now considered a chronic maladaptive inflammatory disease. The hallmark feature in both human and murine disease is atherosclerotic plaques. Macrophages and various T-cell lineages play a crucial role in atherosclerotic plaque establishment and disease progression. Humans and mice share many of the same processes that occur within atherogenesis. The various similarities enable considerable insight into disease mechanisms and those which contribute to cardiovascular complications. The apolipoprotein E-null and low-density lipoprotein receptor-null mice have served as the foundation for further immunological pathway manipulation to identify pro- and antiatherogenic pathways in attempt to reveal more novel therapeutic targets. In this review, we provide a translational perspective and discuss the roles of macrophages and various T-cell lineages in contrasting proatherosclerotic and atheroprotective settings.

1 November 2020 in Respiratory Medicine
Verified
Journal Article
Closed access
SLSilvia Lee
Silvia Lee
DBDavid Birnie
David Birnie
GDGirish Dwivedi
Girish Dwivedi

6 March 2017 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
SLSilvia Lee
Silvia Lee
JAJacquita S. Affandi
Jacquita S. Affandi
AIAshley Irish
Ashley Irish
PPPatricia Price
Patricia Price

Verified
Journal Article
Open access
PDF file
SLSilvia Lee
Silvia Lee
BBBenjamin Bartlett
Benjamin Bartlett
GDGirish Dwivedi
Girish Dwivedi
Atherosclerosis is a chronic inflammatory disease that is initiated by the deposition and accumulation of low-density lipoproteins in the artery wall. In this review, we will discuss the role of T- and B-cells in human plaques at different stages of atherosclerosis and the utility of profiling circulating immune cells to monitor atherosclerosis progression. Evidence supports a proatherogenic role for intraplaque T helper type 1 (Th1) cells, CD4+CD28null T-cells, and natural killer T-cells, whereas Th2 cells and regulatory T-cells (Treg) have an atheroprotective role. Several studies indicate that intraplaque T-cells are activated upon recognition of endogenous antigens including heat shock protein 60 and oxidized low-density lipoprotein, but antigens derived from pathogens can also trigger T-cell proliferation and cytokine production. Future studies are needed to assess whether circulating cellular biomarkers can improve identification of vulnerable lesions so that effective intervention can be implemented before clinical manifestations are apparent.

Verified
Journal Article
Open access
PDF file
SWShelley Waters
Shelley Waters
SLSilvia Lee
Silvia Lee
MLMegan L Lloyd
Megan L Lloyd
AIAshley Irish
Ashley Irish
Patricia PricePatricia Price
Patricia Price
Human cytomegalovirus (CMV) is often transmitted through saliva. The salivary gland is a site of CMV replication and saliva can be used to diagnose congenital CMV infections. CMV replication is monitored in whole blood or plasma in renal transplant recipients (RTR) and associates with clinical disease. However, these assays may not detect replication in the salivary gland and there is little data linking detection in saliva with systemic infection and clinical sequelae. RTR (n = 82) were recruited > 2 years after transplantation. An in-house quantitative PCR assay was used to detect CMV UL54 in saliva samples. CMV DNA was sought in plasma using a commercial assay. Vascular health was predicted using flow mediated dilatation (FMD) and plasma biomarkers. CMV-reactive antibodies were quantified by ELISA and circulating CMV-specific T-cells by an interferon-γ ELISpot assay. Vδ2− γδ T-cells were detected using multicolor flow cytometry reflecting population expansion after CMV infection. The presence of CMV DNA in saliva and plasma associated with plasma levels of antibodies reactive with CMV gB and with populations of circulating Vδ2− γδ T -cells (p < 0.01). T-cells reactive to CMV immediate early (IE)-1 protein were generally lower in patients with CMV DNA in saliva or plasma, but the level of significance varied (p = 0.02–0.16). Additionally, CMV DNA in saliva or plasma associated weakly with impaired FMD (p = 0.06–0.09). The data suggest that CMV detected in saliva reflects systemic infections in adult RTR.

28 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
BBBenjamin Bartlett
Benjamin Bartlett
HLHerbert Ludewick
Herbert Ludewick
SLSilvia Lee
Silvia Lee
SVShipra Verma
Shipra Verma
RFRoslyn J. Francis
Roslyn J. Francis
GDGirish Dwivedi
Girish Dwivedi
Acute coronary syndrome (ACS) describes a range of conditions associated with the rupture of high-risk or vulnerable plaque. Vulnerable atherosclerotic plaque is associated with many changes in its microenvironment which could potentially cause rapid plaque progression. Present-day PET imaging presents a plethora of radiopharmaceuticals designed to image different characteristics throughout plaque progression. Improved knowledge of atherosclerotic disease pathways has facilitated a growing number of pathophysiological targets for more innovative radiotracer design aimed at identifying at-risk vulnerable plaque and earlier intervention opportunity. This paper reviews the efficacy of PET imaging radiotracers 18F-FDG, 18F-NaF, 68Ga-DOTATATE, 64Cu-DOTATATE and 68Ga-pentixafor in plaque characterisation and risk assessment, as well as the translational potential of novel radiotracers in animal studies. Finally, we discuss our murine PET imaging experience and the challenges encountered.